Medical Imaging News and Research

RSS

Esaote acquires 3mensio

Esaote International NV and 3mensio Medical Imaging BV have entered into an agreement pursuant to which Esaote acquires 3mensio in order to expand its leading role in healthcare information technology.

4 Apr 2011

Royal Inland announces radical cut in outpatient x-ray services

Yesterday, Royal Inland Hospital announced a radical cut in outpatient x-ray services, with no consultation with the community.

2 Apr 2011

Oncology experts educate lawmakers about latest information on radiation therapy

Leaders from the radiation oncology community – representing patients, physicians, providers, and manufacturers – met on Capitol Hill today to educate lawmakers and their staffs about the latest in radiation therapy technologies and techniques, improvements in patient care and the community's focus on patient safety in radiation therapy delivery.

1 Apr 2011

McKesson releases Horizon Cardiology 12.2 cardiovascular information system

With its new 12.2 software release, McKesson's Horizon Cardiology™ is the industry's only cardiovascular information system (CVIS) system that offers a single database, including hemodynamics, and presents the entire patient history from fetal to adulthood.

31 Mar 2011

Radiation oncologists head to Capitol Hill to promote critical initiatives

More than 100 radiation oncology treatment team members and resident physicians convened in Washington Monday and Tuesday to represent radiation oncology on Capitol Hill at the American Society for Radiation Oncology's (ASTRO) eighth annual Advocacy Day. Participants spent Monday hearing from members of Congress and key congressional staff on the latest legislative activity and ASTRO'’s legislative agenda. On Tuesday, the group headed to House and Senate office buildings to meet with senators, congressmen and staffers from their home states to promote agenda items important to the safety and well-being of cancer patients.

30 Mar 2011

Oral antioxidant formulation before medical imaging may minimize cell damage

A unique formulation of antioxidants taken orally before imaging with ionizing radiation minimizes cell damage, noted researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

UC San Diego student to make medical imaging available in low-income countries

Benjamin Johnson, a fourth-year student at the University of California, San Diego School of Medicine is determined to make medical imaging technology widely available in low-income countries. His journey started in Uganda, where currently just 35 local radiologists serve the needs of 30 million people.

29 Mar 2011

Ohio engineers invent new fluorescent nano-particle to tag molecules in biomedical tests

Engineers at Ohio State University have invented a new kind of nano-particle that shines in different colors to tag molecules in biomedical tests.

29 Mar 2011

ACRIN, ECOG, NCI intent to merge their clinical cancer research programs

The American College of Radiology's Imaging Network and the Eastern Cooperative Oncology Group, National Cancer Institute Clinical Trials Cooperative Group members, today announced their intent to merge their clinical cancer research programs.

19 Mar 2011

Scientists to develop new MR imaging techniques for brain study

A Norwegian research centre is developing new magnetic resonance imaging techniques to study the brain. This could have impact for victims of brain damage as well as Alzheimer patients.

19 Mar 2011

M7T, MGH collaborate to implement Keystone Engine for radiology workflow scenario

Mach 7 Technologies, a global provider of vendor neutral medical image management solutions, has collaborated with Massachusetts General Hospital to implement Keystone Engine to improve a highly specialized radiology department workflow scenario.

18 Mar 2011

Lantheus proposes $150 million 9.750% Senior Notes offering

Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.

16 Mar 2011

Advances in imaging ability to discover heart defects in newborns

The Medical Imaging Laboratory in Trondheim is making advances in imaging methods for both ultrasound and magnetic resonance (MR) imaging. One benefit will be an enhanced ability to discover heart defects in newborns.

16 Mar 2011

Gadavist approved by FDA for use in central nervous system MRI scans

The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system.

16 Mar 2011

Medidata fourth quarter net revenue is $47.4 million for 2010

Medidata Solutions, a leading global provider of SaaS-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter 2010 and full year ended December 31, 2010, as well as provided financial guidance for the first quarter and full year 2011.

15 Mar 2011

Fysicon to customize Merge solutions for BeNeLux market

Merge Healthcare Incorporated, a global corporation dedicated to health IT interoperability solutions, today announced the expansion of its existing software relationship with Fysicon, the dominant Dutch distributor of medical imaging solutions for radiology and cardiology. Fysicon will customize Merge solutions to improve its specific portfolio of image management products for the BeNeLux market

14 Mar 2011

Understand radiology benefits and risks before undergoing scans: ACR

As part of Patient Safety Awareness Week, the American College of Radiology (ACR) reminds patients that everyone should understand radiology benefits and risks before they or a loved one receives an X-ray, computed tomography (CT) scan or other medical imaging exam.

11 Mar 2011

FDA approves Lantheus Medical Imaging's SPA for flurpiridaz F-18 Phase 3 trial in coronary artery disease

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design and planned analysis of a Phase 3 clinical trial for the assessment of myocardial perfusion using Positron Emission Tomography (PET) imaging of flurpiridaz F-18 in patients with suspected or known coronary artery disease (CAD).

11 Mar 2011

Lantheus commences solicitation with respect to 9.750% Senior Notes Due 2017

Lantheus Medical Imaging, Inc. today announced it commenced a consent solicitation with respect to a proposed amendment to the indenture governing the company's outstanding 9.750% Senior Notes Due 2017.

5 Mar 2011

Cancer patients' willingness to undergo tests bodes well for future of personalized medicine

Cancer patients are willing to undergo many tests to receive advanced experimental treatment in clinical trials, according to a new study by Mayo Clinic, Scottsdale Healthcare and the Translational Genomics Research Institute.

4 Mar 2011